Toxic effect of zinc nanoscale metal-organic frameworks on rat pheochromocytoma (PC12) cells in vitro

Journal of Hazardous Materials

Volumn 271, Issue , 2014, Pages 283-291

  Ren, Fei ^a   Yang, Baochun ^a   Cai, Jing ^a   Jiang, Yaodong ^a   Xu, Jun ^a   Wang, Shan ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Biocompatibility; Cytotoxocity; Metal organic frameworks; PC 12 cells; Toxic effect

Indexed keywords

BIOCOMPATIBILITY; CELLS; CONTROLLED DRUG DELIVERY; CYTOLOGY; INDUSTRIAL POISONS; MEDICAL APPLICATIONS; METAL-ORGANIC FRAMEWORKS; MOLECULAR BIOLOGY; MORPHOLOGY; NANOTECHNOLOGY; ORGANOMETALLICS; PROTEINS; RATS; TARGETED DRUG DELIVERY; ZINC;

BIOMEDICAL APPLICATIONS; CONCENTRATION-DEPENDENT; CYTOTOXOCITY; INTRACELLULAR CONCENTRATION; METALORGANIC FRAMEWORKS (MOFS); PC-12 CELLS; SIGNALING PATHWAYS; TOXIC EFFECT;

CELL SIGNALING;

METAL ORGANIC FRAMEWORK; NANOPARTICLE; NEUROMODULIN; ZINC ION; METAL NANOPARTICLE; NERVE GROWTH FACTOR; ORGANOMETALLIC COMPOUND; ZINC;

CYTOLOGY; GENE EXPRESSION; HOMEOSTASIS; NANOTECHNOLOGY; POLLUTION EFFECT; PROTEIN; RODENT; TOXICITY; VIABILITY;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CELL DIFFERENTIATION; CELL LEVEL; CELL MEMBRANE; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; CYTOSOL; CYTOTOXICITY; DOWN REGULATION; ENDOCYTOSIS; IN VITRO STUDY; NANOTOXICOLOGY; NONHUMAN; PC12 CELL; PHEOCHROMOCYTOMA CELL; PROTEIN EXPRESSION; RAT; ZINC METABOLISM; ANIMAL; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; NEURITE; PC12 CELL LINE; TOXICITY;

ANIMALS; CELL SURVIVAL; CYTOSKELETON; GAP-43 PROTEIN; METAL NANOPARTICLES; NERVE GROWTH FACTOR; NEURITES; ORGANOMETALLIC COMPOUNDS; PC12 CELLS; RATS; ZINC;

EID: 84896071441     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2014.02.026     Document Type: Article

References (43)

1. Della R.J., Liu D.M., Lin W.B. Nanoscale metal-organic frameworks for biomedical imaging and drug delivery. Acc. Chem. Res. 2011, 44:957-968.
2. Horcajada P., Gref R., Allan T., Baati P.K., Maurin G., Couvreur P., Férey G., Morris R.E., Serre C. Metal-organic frameworks in biomedicine. Chem. Rev. 2012, 112:1232-1268.
3. Dinca M., Long J.R. Hydrogen storage in microporous metal-organic frameworks with exposed metal sites. Angew. Chem. Int. Ed. 2008, 47:6766-6779.
4. Horcajada P., Chalati T., Serre C., Gillet B., Sebrie C., Baati T., Eubank J.F., Heurtaux D., Clayette P., Kreuz C., et al. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat. Mater. 2010, 9:172-178.
5. Rieter W.J., Pott K.M., Taylor K.M., Lin W.B. Nanoscale coordination polymers for platinum-based anticancer drug delivery. J. Am. Chem. Soc. 2008, 130:11584-11585.
6. Taylor K.M., Della R.J., Xie Z., Tran S., Lin W.B. Postsynthetic modifications of iron-carboxylate nanoscale metal-organic frameworks for imaging and drug delivery. J. Am. Chem. Soc. 2009, 131:14261-14263.
7. Taylor K.M., Jin A., Lin W.B. Surfactant-assisted synthesis of nanoscale gadolinium metal-organic frameworks for potential multimodal imaging. Angew. Chem. Int. Ed. 2008, 47:7722-7725.
8. Rowe M.D., Thamm D.H., Kraft S.L., Boyes S.G. Polymer-modified gadolinium metal-organic framework nanoparticles used as multifunctional nanomedicines for the targeted imaging and treatment of cancer. Biomacromolecules 2009, 10:983-993.
9. Huxford R.C., Della R.J., Lin W.B. Metal-organic frameworks as potential drug carriers. Curr. Opin. Chem. Biol. 2010, 14:262-268.
10. Cohen S.M. Postsynthetic methods for the functionalization of metal-organic frameworks. Chem. Rev. 2012, 112:970-1000.
11. Baati T., Njim L., Neffati F., Kerkeni A., Bouttemi M., Gref R., Najjar M.F., Zakhama A., Couvreur P., Serre C., Horcajada P. In depth analysis of the in vivo toxicity of nanoparticles of porous iron(III) metal-organic frameworks. Chem. Sci. 2013, 4:1597-1607.
12. Frederickson C.J. Neurobiology of zinc and zinc-containing neurons. Int. Rev. Neurobiol. 1989, 31:145-238.
13. Corniola R.S., Tassabehji N.M., Hare J., Sharma G., Levenson C.W. Zinc deficiency impairs neuronal precursor cell proliferation and induces apoptosis via p53-mediated mechanisms. Brain Res. 2008, 1237:52-61.
14. Balaji R.V., Colvin R.A. A proton-dependent zinc uptake in PC12 cells. Neurochem. Res. 2005, 30:171-176.
15. Rauhala P., Andoh T., Chiueh C.C. Neuroprotective properties of nitric oxide and S-nitrosoglutathione. Toxicol. Appl. Pharmacol. 2005, 207:91-95.
16. Boes A.K., Xiao B., Megson I.L., Morris R.E. Simultaneous gas storage and catalytic gas production using zeolites - a new concept for extending lifetime gas delivery. Top. Catal. 2009, 52:35-41.
17. Nguyen J.G., Tanabe K.K., Cohen S.M. Postsynthetic diazeniumdiolate formation and NO release from MOFs. CrystEngComm 2010, 12:2335-2338.
18. Garibay S.J., Wang Z., Tanabe K.K., Cohen S.M. Postsynthetic modification: a versatile approach toward multifunctional metal-organic frameworks. Inorg. Chem. 2009, 48:7341-7349.
19. Sun C.Y., Qin C., Wang X.L., Yang G.S., Shao K.Z., Lan Y.Q., Su Z.M., Huang P., Wang C.G., Wang E.B. Zeolitic imidazolate framework-8 as efficient pH-sensitive drug delivery vehicle. Dalton Trans. 2012, 41:6906-6909.
20. Tanabe K.K., Wang Z., Cohen S.M. Systematic functionalization of a metal-organic framework via a postsynthetic modification approach. J. Am. Chem. Soc. 2008, 130:8508-8517.
21. Rowsell Jesse L.C., Yaghi O.M. Effects of functionalization, catenation, and variation of the metal oxide and organic linking units on the low-pressure hydrogen adsorption properties of metal-organic frameworks. J. Am. Chem. Soc. 2006, 128:1304-1315.
22. Pavlica S., Gaunitz F., Gebhardt R. Comparative in vitro toxicity of seven zinc-salts towards neuronal PC12 cells. Toxicol. In Vitro 2009, 23:653-659.
23. Kim J.A., Lee N., Kim B.H., Rhee W.J., Yoon S., Hyeon T., Park T.H. Enhancement of neurite outgrowth in PC12 cells by iron oxide nanoparticles. Biomaterials 2011, 32:2871-2877.
24. Wang F., Jiao C., Liu J., Yuan H., Lan M., Gao F. Oxidative mechanisms contribute to nanosize silican dioxide-induced developmental neurotoxicity in PC12 cells. Toxicol. In Vitro 2011, 25:1548-1556.
25. Jeong Y.S., Oh W.K., Kim S., Jang J. Cellular uptake, cytotoxicity, and ROS generation with silica/conducting polymer core/shell nanospheres. Biomaterials 2011, 32:7217-7225.
26. Zhang Y., Xu Y., Li Z., Chen T., Lantz S.M., Howard P.C., Paule M.G., Slikker W., Watanabe F., Mustafa T., et al. Mechanistic toxicity evaluation of uncoated and PEGylated single-walled carbon nanotubes in neuronal PC12 cells. ACS Nano 2011, 5:7020-7033.
27. Neibert K.D., Maysinger D. Mechanisms of cellular adaptation to quantum dots-the role of glutathione and transcription factor EB. Nanotoxicology 2012, 6:249-262.
28. Soenen S.J., Manshian B., Montenegro J.M., Amin F., Meermann B., Thiron T., Cornelissen M., Vanhaecke F., Doak S., Parak W.J., et al. Cytotoxic effects of gold nanoparticles: a multiparametric study. ACS Nano 2012, 6:5767-5783.
29. Pisanic T.R., Blackwell J.D., Shubayev V.I., Fiñones R.R., Jin S. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 2007, 28:2572-2581.
30. Soenen S.J., Himmelreich U., Nuytten N., Cuyper M.D. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labeling. Biomaterials 2011, 32:195-205.
31. Gunawardena S., Her L.S., Brusch R.G., Laymon R.A., Niesman I.R., Gordesky G.B., Sintasath L., Bonini N.M., Goldstein L.S. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in drosophila. Neuron 2003, 40:25-40.
32. Shi W., Gong P., Fan J., Yan Y.H., Ni L., Wu X., Gu X., Chen J. The expression pattern of ADP-ribosyltransferase 3 in rat traumatic brain injury. J. Mol. Histol. 2012, 43:37-47.
33. Skene J.H., Jacobson R.D., Snipes G.J., McGuire C.B., Norden J.J., Freeman J.A. A protein induced during nerve growth (GAP-43) is a major component of growth-cone membranes. Science 1986, 233:783-786.
34. Chen C.J., Liao S.L. Neurotrophic and neurotoxic effects of zinc on neonatal cortical neurons. Neurochem. Int. 2003, 42:471-479.
35. Moreira P., Pereira C., Santos M.S., Oliveira C. Effect of zinc ions on the cytotoxicity induced by the amyloid beta-peptide. Antioxid. Redox. Signal 2000, 2:317-325.
36. Cherny R.A., Atwood C.S., Xilinas M.E., Gray D.N., Jones W.D., McLean C.A., Barnham K.J., Volitakis I., Fraser F.W., Kim Y., et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 2001, 30:665-676.
37. Capasso M., Jeng J.M., Malavolta M., Mocchegiani E., Sensi S.L. Zinc dyshomeostasis: a key modulator of neuronal injury. J. Alzheimers Dis. 2005, 8:93-108. discussion 209-215.
38. Brewer G.J., Kanzer S.H., Zimmerman E.A., Molho E.S., Celmins D.F., Heckman S.M., Dick R. Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease. Am. J. Alzheimers. Dis. Other Demen. 2010, 25:572-575.
39. Gundelfinger E.D., Boeckers T.M., Baron M.K., Bowie J.U. A role for zinc in postsynaptic density asSAMbly and plasticity. Trends Biochem. Sci. 2006, 31:366-373.
40. Kao Y.Y., Cheng T.J., Yang D.M., Wang C.T., Chiung Y.M., Liu P.S. Demonstration of an olfactory bulb-brain translocation pathway for ZnO nanoparticles in rodent cells in vitro and in vivo. J. Mol. Neurosci. 2012, 48:464-471.
41. Zhang J.Y., Song W.H., Guo J., Zhang J.H., Sun Z.T., Ding F., Gao M.L. Toxic effect of different ZnO particles on mouse alveolar macrophages. J. Hazard. Mater. 2012, 219-220:148-155.
42. Aimo L., Cherr G.N., Oteiza P.I. Low extracellular zinc increases neuronal oxidant production through nadph oxidase and nitric oxide synthase activation. Free Radic. Biol. Med. 2010, 48:1577-1587.
43. Chesters J.K., Petrie L. A possible role for cyclins in the zinc requirements during G1 and G2 phases of the cell cycle. J. Nutr. Biochem. 1999, 10:279-290.